Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Toplak, H; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B.
[Obesity and type 2 diabetes].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S196-S200
Doi: 10.1007/s00508-016-0986-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Toplak Hermann
- Co-Autor*innen der Med Uni Graz
- Wascher Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Obesity and Type 2 Diabetes are nowadays summarized as "diabesity". That is due to the fact that obesity is frequently preceding and the most important risk factor in the increase of Type 2 Diabetes. The body mass index (BMI) is a crude measure of body fatness. Even normal weight persons can have lack in muscles (sarcopenia), which leads to the recommendation to measure waist und body fatness (e.g. BIA). Lifestyle management including nutrition and physical activity are important for diabetes prevention. In the therapy of Type 2 Diabetes body weight is increasingly used as secondary target. Also the choice of the anti-diabetic medication and concomitant medications is increasingly influenced by body weight. The significance of anti-obesity medications in the therapy of type 2 diabetes will have to be clarified by future studies. Bariatric surgery is at present indicated with a BMI above BMI > 35 kg/m(2) and can lead at least to partial diabetes remission but has to be part of a lifelong care concept.
- Find related publications in this database (using NLM MeSH Indexing)
- Anti-Obesity Agents - administration & dosage
- Austria -
- Bariatric Surgery - standards
- Diabetes Mellitus, Type 2 - diagnosis
- Diabetes Mellitus, Type 2 - etiology
- Diabetes Mellitus, Type 2 - therapy
- Diet Therapy - standards
- Dose-Response Relationship, Drug -
- Drug Administration Schedule -
- Evidence-Based Medicine -
- Exercise Therapy - standards
- Humans -
- Hypoglycemic Agents - administration & dosage
- Obesity - complications
- Obesity - diagnosis
- Obesity - therapy
- Practice Guidelines as Topic -
- Risk Reduction Behavior -
- Treatment Outcome -
- Find related publications in this database (Keywords)
- Obesity
- Typ 2 diabetes